| 747698 |
FRONTIERS IN ONCOLOGY |
Application of Deep Convolution Network to Automated Image Segmentation of Chest CT for Patients With Tumor |
2021-09-29 |
10.3389/fonc.2021.719398 |
Xie Hui, Zhang Jian-Fang, Li Qing |
| 747697 |
FRONTIERS IN ONCOLOGY |
Survival-Weighted Health Profiles in Patients Treated for Advanced Oral Cavity Squamous Cell Carcinoma |
2021-09-29 |
10.3389/fonc.2021.754412 |
Tsai Yao-Te, Chen Wen-Cheng, Hsu Cheng-Ming, Tsai Ming-Shao, Chang Geng-He, Lee Yi-Chan, Huang Ethan I., Fang Chiung-Cheng, Lai Chia-Hsuan |
| 747696 |
FRONTIERS IN ONCOLOGY |
CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis |
2021-09-29 |
10.3389/fonc.2021.658139 |
Shi Zuowei, Wang Kaifu, Xing Yufei, Yang Xuefeng |
| 747695 |
FRONTIERS IN ONCOLOGY |
Short-Term Clinical Efficacy of Neoadjuvant Chemotherapy Combined With Laparoscopic Gastrectomy for Locally Advanced Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Propensity Score-Matched Study |
2021-09-29 |
10.3389/fonc.2021.690662 |
Feng Qing, Long Du, Du Ming-shan, Wang Xiao-song, Li Zhen-shun, Zhao Yong-liang, Qian Feng, Wen Yan, Yu Pei-wu, Shi Yan |
| 747694 |
FRONTIERS IN ONCOLOGY |
Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment |
2021-09-29 |
10.3389/fonc.2021.719919 |
Tang Xin, Li Yuan, Yan Wei-feng, Qian Wen-lei, Pang Tong, Gong You-ling, Yang Zhi-gang |
| 747693 |
FRONTIERS IN ONCOLOGY |
Metal-Regulatory Transcription Factor-1 Targeted by miR-148a-3p Is Implicated in Human Hepatocellular Carcinoma Progression |
2021-09-29 |
10.3389/fonc.2021.700649 |
Lyu Zhuozhen, Yang Mingyu, Yang Tan, Ma Mingze, Yang Zhen |
| 747692 |
FRONTIERS IN ONCOLOGY |
Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment |
2021-09-29 |
10.3389/fonc.2021.650603 |
Buhrmann Constanze, Kunnumakkara Ajaikumar B., Kumar Aviral, Samec Marek, Kubatka Peter, Aggarwal Bharat B., Shakibaei Mehdi |
| 747691 |
FRONTIERS IN ONCOLOGY |
Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics |
2021-09-29 |
10.3389/fonc.2021.619817 |
Mampunye Lwando, van der Merwe Nerina C., Grant Kathleen A., Peeters Armand V., Torrorey-Sawe Rispah, French David J., Moremi Kelebogile E., Kidd Martin, van Eeden Petrus C., Pienaar Fredrieka M., Kotze Maritha J. |
| 747690 |
FRONTIERS IN ONCOLOGY |
Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma |
2021-09-29 |
10.3389/fonc.2021.757498 |
Xu Lin, Wang Peng, Zhang Wei, Li Weiran, Liu Tao, Che Xu |
| 747689 |
FRONTIERS IN ONCOLOGY |
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation” |
2021-09-29 |
10.3389/fonc.2021.708073 |
Zuccolotto Gaia, Penna Alessandro, Fracasso Giulio, Carpanese Debora, Montagner Isabella Monia, Dalla Santa Silvia, Rosato Antonio |
